Redx to move HQ and development ops to ex-AstraZeneca site in Cheshire

By Gareth Macdonald contact

- Last updated on GMT

Redx to set up HQ at former AstraZeneca R&D site
Redx to set up HQ at former AstraZeneca R&D site

Related tags: Cancer

Redx Pharma has announced plans to set up a development facility and new headquarters in Alderly Park, Cheshire.

The firm said the move would bring together its three subsidiaries: Redx anti-infectives and Redx immunology which are already based at the site; and Redx oncology, which is currently based at Royal Liverpool Hospital.

The news follows a day after Redx announced a new share offering.

A spokesman for the firm told us "Redx is leasing lab space, not buying the building so the Alderley Park relocation is un-related to the recent fundraising​."

He added that: "All staff at Redx in Liverpool will be retained – no jobs will be lost and no one is leaving the business. Alderley Park is reasonably local to Liverpool​."

Redx plans to complete the move by the end of the year.

The Alderly Park site was sold by AstraZeneca to Manchester Science Parks – a public-private partnership – in 2014​, 

Redx CEO Neil Murray said: “Alderley Park’s high specification laboratories and superlative facilities present a commercially attractive solution as we seek to provide the best infrastructure and environment for our staff.

The site has a great history as a global leader in cancer research and we look forward to adding Redx drugs to the roll call of successful cancer therapies that ICI and AstraZeneca produced over the years​.”

Related topics: Contract Manufacturing & Logistics

Related news

Show more

Follow us

Products

View more

Webinars